Clinical Trials and Research

Measuring blood levels of a protein called neurofilament light chain (NfL) may help identify nerve damage in people with hereditary transthyretin amyloidosis with…

DelveInsight's "Cardiac Amyloidosis Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Cardiac Amyloidosis,…

Scientific Frontline: Extended "At a Glance" Summary: Hereditary ATTR Amyloidosis and Redox ImbalanceThe Core Concept: Hereditary ATTR amyloidosis is a progressive…

AbstractBackgroundVal142Ile hereditary transthyretin amyloidosis (hATTR) is an underrecognized cause of heart failure with preserved ejection fraction (HFpEF) in…

AbstractHereditary transthyretin amyloidosis (ATTRv) is a progressive, life-threatening disease caused by mutations in the TTR gene. It is characterized by marked…

AbstractTransthyretin cardiac amyloidosis (ATTR-CM) is an increasingly recognized infiltrative cardiomyopathy characterized by progressive myocardial amyloid…

Immunoglobulin light chain (AL) amyloidosis and POEMS syndrome are plasma cell proliferative disorders involving multiple organs and tissues, often presenting with…

AbstractLight chain (AL) amyloidosis is a systemic disorder caused by plasma cell dyscrasia, with cardiac involvement being the primary determinant of prognosis.…

AbstractCardiovascular amyloidosis affects the health of a significant proportion of the global population. These diseases are characterised by the deposition of…

AbstractBackgroundCardiac amyloidosis (CA) is an infiltrative cardiomyopathy associated with adverse outcomes. Quantification of myocardial amyloid burden is…